Antigen Rapid Test Market, by Type (Enzyme Linked Immunosorbent Assay (ELISA), Chemiluminescence Immunoassay (CIA)), by Application (Infectious Diseases, Oncology, Immunoendocrinology) and, by End-User (Hospitals and Clinics, Laboratories, Research Institutes): Opportunity Analysis and Industry Forecast, 2023-2032

The study on the Antigen rapid test market offers insights, information, and recommendation to market stakeholders and investors to help them prioritize and formulate strategic decisions. The report includes Antigen rapid test market across more than 15 countries. The study is analyzed on the basis of rigorous research methodology, which covers extensive desk research using qualitative analysis, quantitative/statistical methods, and primary interviews.

The study analyzes the market scope, revenue size, and growth of the global Antigen rapid test market and monitors the prime trends at the regional level. In addition, it covers qualitative analysis on the basis of several parameters, including impact on market size, economic impact, regulatory framework, opportunity window, and key player strategies. The report includes a section on the company profile that covers the company overview, company snapshot, key executives, product/service portfolio, operating business segments, business performance, R&D expenditure, and key strategic moves & developments. The global Antigen rapid test market is categorized on the basis of by type, by application, by end-user. On the basis of region, the market is studied across North America (the U.S., Canada, and Mexico), Europe (the UK, Germany, France, Spain, Italy, and rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia, and rest of Asia-Pacific), and LAMEA (Latin America, the Middle East, and Africa).

Key players covered in this report are BioMedomics Inc., Bio-Rad Laboratories Inc., Cell Method Far East Co. Ltd., Danaher Corporation, Johnson and Johnson Services Inc., Merck Group, Qiagen N.V., Siemens AG, Sarstedt AG and Co., Thermo Fisher Scientific Inc.

Deliverables:

• Market size value forecast by country

• Regional-level market trends and market dynamics

• Porter’s five forces model and PESTLE Analysis

• Company profile, competition landscape inclusive of heatmap analysis, competition dashboard and product/service offerings

• Major developmental strategies and M&A activities

• Country-wise market size and forecast for each segment

• Market share of leading players worldwide

Market Taxonomy

This report divides the global Antigen rapid test market on the basis of by type, by application, by end-user. On the basis of region, the global Antigen rapid test market analyzed across North America; Europe; Asia-Pacific; and Latin America, the Middle East, and Africa.

  Antigen Rapid Test Market Report Highlights

Aspects	Details
By Type	Enzyme Linked Immunosorbent Assay (ELISA) Chemiluminescence Immunoassay (CIA)
By Application	Infectious Diseases Oncology Immunoendocrinology
By End-User	Hospitals and Clinics Laboratories Research Institutes
By Region	North America  (U.S., Canada, Mexico) Europe  (France, Germany, Italy, Spain, UK, Russia, Rest of Europe) Asia-Pacific  (China, Japan, India, South Korea, Australia, Thailand, Malaysia, Indonesia, Rest of Asia-Pacific) LAMEA  (Brazil, South Africa, Saudi Arabia, UAE, Argentina, Rest of LAMEA)
Key Market Players	Siemens AG, Sarstedt AG and Co., Bio-Rad Laboratories Inc., Johnson and Johnson Services Inc., Thermo Fisher Scientific Inc., Cell Method Far East Co. Ltd., Merck Group, Danaher Corporation, Qiagen N.V., BioMedomics Inc.

^*Terms and Conditions Apply